Abbott Laboratories has made an open offer for a 20 per cent stake in Solvay Pharma India Ltd, through its subsidiary Abbott Capital India Ltd, the company said in a communique to the Bombay Stock Exchange today. DSP Merrill Lynch is the Manager to the offer.

Abbott seeks to acquire around one million equity shares with voting rights at a price of Rs 3,054.73 a share, in a deal valued at Rs 308.51 crore.

BSE  |  NSE Price

Click here to visit SME Buzz

Also Read   Related Stories News Now - Delhi HC stays patent revocation of Abbott's drug - Wockhardt-Abbot deal gets high court go-ahead - Dishman pharma forms JV to make API in Saudi Arabia - Abbott's Solvay buy likely to aid Indian subsidiaries - Aurobindo gets tentative nod for anti-HIV drug - India Inc's M&As touch $2.5bn in Jan: Thornton   Also Read   Related Stories News Now - Markets: A day of quiet consolidation - RBI study doubts efficacy of price data for monetary policy - Mahindra & Mahindra to launch passenger vehicle variant - Organic industry targets Rs 4,000 cr by 2012 - Kotak Life launches 2 new Ulips More

Shares of Solvay Pharma were up 0.93 per cent at Rs 2,881  in afternoon trade on the Bombay Stock Exchange.

Other Stories      - Markets: A day of quiet consolidation - RBI study doubts efficacy of price data for monetary policy - Mahindra & Mahindra to launch passenger vehicle variant - Organic industry targets Rs 4,000 cr by 2012 - Kotak Life launches 2 new Ulips More

Tags : solvay pharma | Abbott Laboratories | Pharma industry | M&A | DSP Merrill Lynch   Read Business news in  Advertisements    Banking Solutions that are a perfect fit. Know more    Your 1st Step in Share markets with Sharekhan!    Click here to visit Business Standard SME Buzz    Required telecallers in Mumbai full time or part time...    5lacs to invest? Contact Sharekhan's PMS Advisor   GiftwithLove.com: Same Day Delivery of Flowers/ Cake/Gift in India